Who owns Vir Biotechnology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VIR from SEC Form 13F filings across 267 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 267 institutions disclosed 140.1M shares of Vir Biotechnology, Inc. worth $1.57B — about 82.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
267
13F holders
$1.57B
value, 2026 filers
82.8%
of shares outstanding (140.1M sh)
56
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of VIR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 22.4M | $251.0M | 0.0% | 13.3% | +8.6% |
| 2 | ARCH Venture Management, LLC | 12.7M | $141.9M | 8.8% | 7.5% | 0.0% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 12.0M | $134.4M | 0.0% | 7.1% | +4.6% |
| 4 | SB INVESTMENT ADVISERS (UK) LTD | 10.9M | $122.4M | 2.0% | 6.5% | 0.0% |
| 5 | GSK plc | 8.6M | $95.6M | 19.2% | 5.1% | 0.0% |
| 6 | STATE STREET CORP | 7.8M | $87.5M | 0.0% | 4.6% | -21.5% |
| 7 | Point72 Asset Management, L.P. | 6.8M | $75.7M | 0.1% | 4% | +19.5% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 6.4M | $72.1M | 0.0% | 3.8% | +1.0% |
| 9 | DIMENSIONAL FUND ADVISORS LP | 3.3M | $37.1M | 0.0% | 2% | +6.3% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 3.0M | $33.8M | 0.0% | 1.8% | -9.8% |
| 11 | MPM BIOIMPACT LLCNEW | 2.8M | $31.4M | 2.3% | 1.7% | new |
| 12 | Nuveen, LLC | 2.2M | $24.8M | 0.0% | 1.3% | +12.0% |
| 13 | ADAR1 Capital Management, LLC | 2.2M | $24.1M | 1.1% | 1.3% | -12.1% |
| 14 | Saturn V Capital Management LP | 2.0M | $22.8M | 3.3% | 1.2% | +164.8% |
| 15 | Pictet Asset Management Holding SA | 1.9M | $21.3M | 0.0% | 1.1% | -2.5% |
| 16 | MORGAN STANLEY | 1.8M | $19.8M | 0.0% | 1% | -19.9% |
| 17 | NORTHERN TRUST CORP | 1.5M | $16.6M | 0.0% | 0.9% | +3.5% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.5M | $16.3M | 0.0% | 0.9% | +10.0% |
| 19 | Hudson Bay Capital Management LP | 1.2M | $13.1M | 0.0% | 0.7% | -13.9% |
| 20 | TWO SIGMA INVESTMENTS, LP | 1.1M | $12.7M | 0.0% | 0.7% | +2.1% |
| 21 | BANK OF AMERICA CORP /DE/ | 1.0M | $11.6M | 0.0% | 0.6% | -9.5% |
| 22 | Sio Capital Management, LLC | 873,375 | $9.8M | 1.8% | 0.5% | -18.8% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 862,635 | $9.6M | 0.0% | 0.5% | +2.5% |
| 24 | GOLDMAN SACHS GROUP INC | 846,616 | $9.5M | 0.0% | 0.5% | -64.2% |
| 25 | Savvy Advisors, Inc. | 837,570 | $9.4M | 0.2% | 0.5% | -19.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.